CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 45 filers reported holding CUREVAC N V in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,037,887 | -60.6% | 298,373 | -39.9% | 0.00% | -100.0% |
| Q2 2023 | $5,175,604 | +193.7% | 496,699 | +96.5% | 0.00% | – |
| Q1 2023 | $1,761,939 | +119.2% | 252,789 | +89.6% | 0.00% | – |
| Q4 2022 | $803,799 | -66.3% | 133,300 | -56.0% | 0.00% | – |
| Q3 2022 | $2,386,000 | -72.8% | 302,801 | -53.1% | 0.00% | -100.0% |
| Q2 2022 | $8,780,000 | -38.2% | 645,147 | -10.9% | 0.00% | +50.0% |
| Q1 2022 | $14,204,000 | -76.8% | 724,269 | -59.4% | 0.00% | 0.0% |
| Q4 2021 | $61,268,000 | +16.2% | 1,785,666 | +85.0% | 0.00% | -71.4% |
| Q3 2021 | $52,725,000 | -60.2% | 965,304 | -46.5% | 0.01% | -61.1% |
| Q2 2021 | $132,514,000 | +30.5% | 1,803,399 | +62.4% | 0.02% | +5.9% |
| Q1 2021 | $101,579,000 | +24.0% | 1,110,638 | +9.9% | 0.02% | +142.9% |
| Q4 2020 | $81,922,000 | +248.4% | 1,010,494 | +100.0% | 0.01% | +40.0% |
| Q3 2020 | $23,515,000 | – | 505,136 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $13,500,000 | 10.67% |
| FOX RUN MANAGEMENT, L.L.C. | 31,522 | $248,000 | 0.10% |
| Green Alpha Advisors, LLC | 12,598 | $99,000 | 0.08% |
| Quantamental Technologies LLC | 10,846 | $85,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 49,034 | $386,000 | 0.03% |
| Virtus ETF Advisers LLC | 7,733 | $61,000 | 0.02% |
| XTX Topco Ltd | 12,040 | $95,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 55,320 | $436,000 | 0.01% |
| TWINBEECH CAPITAL LP | 46,360 | $365,000 | 0.01% |
| Man Group plc | 281,996 | $2,222,000 | 0.01% |